(Q39793030)

English

Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study

scientific article published on 17 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study (English)

1 reference

Europe PubMed Central

14 September 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

systemic therapy

1 reference

based on heuristic

inferred from title

author name string

S Boehncke

1

1 reference

Europe PubMed Central

14 September 2017

R Salgo

2

1 reference

Europe PubMed Central

14 September 2017

J Garbaraviciene

3

1 reference

Europe PubMed Central

14 September 2017

H Beschmann

4

1 reference

Europe PubMed Central

14 September 2017

K Hardt

5

1 reference

Europe PubMed Central

14 September 2017

S Diehl

6

1 reference

Europe PubMed Central

14 September 2017

S Fichtlscherer

7

1 reference

Europe PubMed Central

14 September 2017

D Thaçi

8

1 reference

Europe PubMed Central

14 September 2017

W-H Boehncke

9

1 reference

Europe PubMed Central

14 September 2017

publication date

17 January 2011

1 reference

Europe PubMed Central

14 September 2017

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

14 September 2017

25

1 reference

Europe PubMed Central

14 September 2017

10

1 reference

Europe PubMed Central

14 September 2017

1187-1193

1 reference

Europe PubMed Central

14 September 2017

Psoriasis and its management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Managing comorbid disease in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Psoriasis: a possible risk factor for development of coronary artery calcification.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

The risk of mortality in patients with psoriasis: results from a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Psoriasis patients show signs of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Endothelial dysfunction in insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Insulin resistance and endothelial cell dysfunction: studies in mammalian models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Current severe psoriasis and the rule of tens.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Treatment goals in psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Adipokines, myokines and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Plasma resistin levels and risk of myocardial infarction and ischemic stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Experimental endotoxemia induces adipose inflammation and insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Adipokines, insulin resistance, and coronary artery calcification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2010.03947.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2010.03947.X

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39793030&oldid=2090461924"